Figure 1 | Scientific Reports

Figure 1

From: Mortality and readmission rates among hospitalized COVID-19 patients with varying stages of chronic kidney disease: a multicenter retrospective cohort

Figure 1

(a–c) Unadjusted; age, sex and ethnicity adjusted; and fully adjusted 12-week mortality and readmission odds ratios in patients hospitalized for COVID-19 among CKD groups compared to “no-CKD” with corresponding P values. CKD stage 2 = eGFR 60–79 ml/min/1.73 m2, CKD stage 3a = eGFR 45–59 ml/min/1.73 m2, CKD stage 3b = eGFR 30–44 ml/min/1.73 m2, CKD stage 4 = eGFR 15–29 ml/min/1.73 m2, CKD stage 5 = eGFR < 15 ml/min/1.73 m2, CKD = chronic kidney disease. P is considered significant at P ≤ 0.05.

Back to article page